Loading company…
Shanghai-based provider of integrated drug discovery and development services for pharmaceutical and biotech clients.
Founded in 2004 in Shanghai, China, Sundia MediTech Company, Ltd. offers drug substance and drug product development, antibody-drug conjugates, peptide compound management and PROTAC solutions, with a focus on oncology and pharmacology. In September 2020, BioDuro-Sundia acquired a majority stake in the company. Its latest round was a Series A of CNY 20.000 mn led by IDG Capital, across 3 deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in